161 related articles for article (PubMed ID: 36720505)
1. Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
Turco LC; Pedone Anchora L; Fedele C; Inzani F; Piermattei A; Martini M; Volpe M; Marchetti S; Santangelo R; Bizzarri N; Cosentino F; Vargiu V; De Ninno M; Macchia G; Valentini V; Zannoni G; Scambia G; Ferrandina G
Int J Gynecol Cancer; 2023 Apr; 33(4):489-497. PubMed ID: 36720505
[TBL] [Abstract][Full Text] [Related]
2. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
3. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
Chakrabarti M; Nordin A; Khodabocus J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012246. PubMed ID: 36111784
[TBL] [Abstract][Full Text] [Related]
4. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
5. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
Federico A; Anchora LP; Gallotta V; Fanfani F; Cosentino F; Turco LC; Bizzarri N; Legge F; Teodorico E; Macchia G; Valentini V; Scambia G; Ferrandina G
Ann Surg Oncol; 2022 Aug; 29(8):4806-4814. PubMed ID: 35355131
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus DNA in paraaortic lymph nodes in advanced stages of cervical carcinoma.
Slama J; Drazdakova M; Dundr P; Fischerova D; Zikan M; Pinkavova I; Freitag P; Fanta M; Kuzel D; Zima T; Cibula D
J Clin Virol; 2011 Jan; 50(1):46-9. PubMed ID: 21035386
[TBL] [Abstract][Full Text] [Related]
11. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
Li D; Huang S; Liu K; Qin Y; Zhang Y; Yang Y
Int J Gynecol Cancer; 2022 May; 32(5):599-605. PubMed ID: 35331994
[TBL] [Abstract][Full Text] [Related]
13. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
14. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment response in cervical carcinoma patients infected with human papillomavirus 16 and human papillomavirus 18 who are treated with chemoradiation.
Narayanan GS; Ganesh MS; Kumar R
J Cancer Res Ther; 2021; 17(1):204-210. PubMed ID: 33723156
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
17. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
18. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
Cabel L; Bonneau C; Bernard-Tessier A; Héquet D; Tran-Perennou C; Bataillon G; Rouzier R; Féron JG; Fourchotte V; Le Brun JF; Benoît C; Rodrigues M; Scher N; Minsat M; Legrier ME; Bièche I; Proudhon C; Sastre-Garau X; Bidard FC; Jeannot E
ESMO Open; 2021 Jun; 6(3):100154. PubMed ID: 34022731
[TBL] [Abstract][Full Text] [Related]
19. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
[TBL] [Abstract][Full Text] [Related]
20. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
